Download only This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland. Publication ID SMA14-4854 Publication Date November 2014 Format Report Download Medicaid: Financing Meds to Treat Alcohol, Opioid Use PDF 1.87 MB Find Related Information Audience Policymakers Program Planners, Administrators, & Project Managers Public Health Professionals Population Group People with Alcohol Use or Abuse Problems as Population Group People with Substance Use or Abuse Problems as Population Group You May Also Be Interested In Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. Behavioral Health Equity Barometer, 2014 This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women. Decisions in Recovery: Treatment for Opioid Use Disorders This handbook provides guidance on using the web-based, multimedia tool Decisions in Recovery: Medications for Opioid Addiction. This handbook and the web-based tool offers information about medication-assisted treatment. Both resources help people living with opioid use disorder compare treatment options and discuss their preferences with a provider. TIP 63: Medications for Opioid Use Disorder - Executive Summary The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery. Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.